Thoracic cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy for pseudomyxoma peritonei

Journal of Surgical Oncology

Volumn 99, Issue 5, 2009, Pages 292-295

  Chua, Terence C ^a   Yan, Tristan D ^a   Yap, Zhu L ^a   Horton, Matthew D ^b   Fermanis, Gary C ^b   Morris, David L ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ST GEORGE HOSPITAL   (Australia)

Author keywords

Intrapleural chemotherapy; Intrathoracic chemotherapy; Mitomycin; Pleural neoplasm; Pseudomyxoma peritonei

Indexed keywords

MITOMYCIN C;

ABDOMINAL DISEASE; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; CYTOREDUCTIVE SURGERY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HYPERTHERMIC THERAPY; INTRAOPERATIVE HYPERTHERMIC INTRATHORACIC CHEMOTHERAPY; LONG TERM CARE; MALE; OBSERVATIONAL STUDY; PERITONEUM PSEUDOMYXOMA; PEROPERATIVE CARE; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SURGICAL TECHNIQUE; THORAX DISEASE; THORAX SURGERY; ADJUVANT CHEMOTHERAPY; AGED; FOLLOW UP; INTRAOPERATIVE PERIOD; LENGTH OF STAY; METHODOLOGY; MIDDLE AGED; PERITONEUM TUMOR; REOPERATION; THORACOTOMY; TREATMENT OUTCOME; TUMOR RECURRENCE;

AGED; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; HYPERTHERMIA, INDUCED; INTRAOPERATIVE PERIOD; LENGTH OF STAY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PERITONEAL NEOPLASMS; PSEUDOMYXOMA PERITONEI; REOPERATION; THORACOTOMY; TREATMENT OUTCOME;

EID: 62849112569     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21230     Document Type: Article

References (20)

1. Moran BJ, Cecil TD: The etiology, clinical presentation, and of pseudomyxoma peritonei. Surg Oncol Clin N Am ;12:585-603.
2. Ronnett BM, Zahn CM, Kurman RJ, et al: Disseminated adenomucinosis and peritoneal mucinous carcinoma-. A clinicopathologic analysis of 109 cases with emphasis on pathologic features, site of origin, prognosis, and to pseudomyxoma peritonei. Am J Surg Pathol ;19:1390-1408.
3. Yan TD, Links M, Xu ZY, et al: Cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma from appendiceal mucinous neoplasms. Br J Surg 2006; :1270-1276.
4. Baratti D, Kusamura S, Nonaka D, et al.: Pseudomyxoma peritonei: pathological and biological prognostic factors in patients with cytoreductive surgery and hyperthermic intraperitoneal (HIPEC). Ann Surg Oncol 2008;15:526-534.
5. Ronnett BM, Yan H, Kurman RJ, et al.: Patients with peritonei associated with disseminated peritoneal have a significantly more favorable prognosis patients with peritoneal mucinous carcinomatosis. Cancer ;92:85-91.
6. Yan TD, Black D, Savady R, et al.: A systematic review on the of cytoreductive surgery and perioperative intraperitoneal for pseudomyxoma peritonei. Ann Surg Oncol ;14:484-492.
7. Pestieau SR, Esquivei J, Sugarbaker PH: Pleural extension of tumor in patients with pseudomyxoma peritonei. Ann Surg Oncol 2000;7:199-203.
8. Abu-Hijleh ME Habbal OA, Moqattash ST: The role of the in lymphatic absorption from the peritoneal cavity. J 1995;186:453-467.
9. Jimenez D, Diaz G, Gil D, et al.: Etiology and prognostic of massive pleural effusions. Respir Med 2005 ;99:-1187.
10. Rusch VW, Figlin R, Godwin D, et al.: Intrapleural cisplatin and in the management of malignant pleural effusions: A Cancer Study Group trial. J Clin Oncol 1991;9:313-319.
11. Rusch VW, Niedzwiecki D, Tao Y, et al.: Intrapleural cisplatin and for malignant mesothelioma following pleurectomy: studies. J Clin Oncol 1992;10:1001-1006.
12. Rusch VW: Pleurectomy/decortication in the setting of multi-treatment for diffuse malignant pleural mesothelioma. Thorac Cardiovase Surg 1997;9:367-372.
13. Jacquet P, Sugarbaker PH: Current methodologies for clinical of patients with peritoneal carcinomatosis. J Exp Clin Res 1996;15:49-58.
14. Ellis P, Davies AM, Evans WK, et al.: The use of chemotherapy in with advanced malignant pleural mesothelioma: A review and practice guideline. J Thorac Oncol 2006; :591-601.
15. Schipper PH, Nichols FC, Thomse KM, et al.: Malignant pleural : Surgical management in 285 patients. Ann Thorac 2008;85:257-264; discussion 264.
16. Weder W, Stahel RA, Bernhard J, et al.: Multicenter trial of neo-chemotherapy followed by extrapleural pneumonectomy in pleural mesothelioma. Ann Oncol 2007;18:1196-1202.
17. van Sandick JW, Kappers I, Baas P, et al.: Surgical treatment in management of malignant pleural mesothelioma: A single 's experience. Ann Surg Oncol 2008;15:1757-1764.
18. van Ruth S, Baas P, Haas RLM, et al.: Cytoreductive surgery with intraoperative hyperthermic intrathoracic chemo-for stage I malignant pleural mesothelioma. Ann Surg 2003;10:176-182.
19. Carmignani CP, Sugarbaker TA, Bromley CM, et al.: Intra-cancer dissemination: Mechanisms of the patterns of. Cancer Metastasis Rev 2003;22:465-472.
20. Autio V: The spread of intraperitoneal infection: Studies with contrast medium. Acta Chir Scand Suppl 1964;36:1-31.